trials in healthy adults are small and limited in scope
Neuroprotective Properties Under Investigation The Zagreb groups 2016 review in Current Neuropharmacology described peripheral BPC-157 administration altering serotonin synthesis rates in specific brain regions, particularly nigrostriatal and other dopaminergic pathways (Tohyama, Sikiric, Diksic, 2004, Life Sciences )
Madzhidova S, Sedrakyan L
The 5-amino-1mq dosage protocol we've observed in institutional settings typically starts at 50mg daily for two weeks, then escalates to 75100mg based on tolerance and objective metabolic markers (NAD+ levels, methylnicotinamide urinary excretion)
Life sciences , 54 5, PL63-8
Who might benefit from B12 supplementation